Eric Burg June 25, 2017
Overall PE deals in Europe's pharmaceutical sector have been mixed over the last couple of years. Deal count has been declining, from 49 in 2015 to just 13 so far this year, per the PitchBook Platform. This is on par with the prevailing trend of lower deal count throughout most of the PE industry.
A successful bid by Bain and Cinven would add to that. A failed bid, on the other hand, may well result on in another—likely to be lower—offer from an opportunistic acquirer.